While targeted processing evaluates an injection with respect to the target peptide list, new peak detection allows you to evaluate whether injections contain new, unexpected peaks. In Chromeleon CDS software, new peak detection is referred to as non-targeted MS (NTMS) processing and it is part of a processing method.